Purchases and Sales Made in Q4 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q4 2024. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 04, 2025
Q4 2024
|
Los Angeles Capital Management LLC
|
SELL
|
- |
-94.3K- 75.39% |
$784K - $1.41M
|
30.8K
$401K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-155K- 11.98% |
$1.29M - $2.33M
|
1.14M
$14.9M
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-181K- 94.22% |
$1.5M - $2.71M
|
11.1K
$145K
|
|
|
Feb 10, 2025
Q4 2024
|
Tejara Capital LTD
London, X0 |
SELL
|
- |
-278K- 23.9% |
$2.31M - $4.17M
|
887K
$11.5M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-284K- 17.85% |
$2.36M - $4.25M
|
1.31M
$17M
|
|
|
Feb 06, 2025
Q4 2024
|
Candriam S.C.A.
|
SELL
|
- |
-384K- 26.94% |
$3.19M - $5.76M
|
1.04M
$13.6M
|
|
|
Feb 14, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-412K- 51.56% |
$3.43M - $6.18M
|
388K
$5.05M
|
|
|
Feb 14, 2025
Q4 2024
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-415K- 51.65% |
$3.45M - $6.22M
|
388K
$5.06M
|
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-441K- 54.57% |
$3.66M - $6.61M
|
367K
$4.78M
|
|
|
Feb 14, 2025
Q4 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-500K- 21.51% |
$4.16M - $7.5M
|
1.83M
$23.8M
|
|
|
Feb 14, 2025
Q4 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-502K- 72.43% |
$4.17M - $7.53M
|
191K
$2.49M
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-522K- 7.5% |
$4.34M - $7.82M
|
6.44M
$83.9M
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-639K- 54.38% |
$5.31M - $9.59M
|
536K
$6.98M
|
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-691K- 12.25% |
$5.74M - $10.4M
|
4.95M
$64.5M
|
|
|
Feb 14, 2025
Q4 2024
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-880K- 58.94% |
$7.31M - $13.2M
|
613K
$7.98M
|
|
|
Feb 12, 2025
Q4 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-941K- 22.14% |
$7.82M - $14.1M
|
3.31M
$43.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
- |
-1.28M- 71.83% |
$10.6M - $19.1M
|
501K
$6.52M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-2.94M- 97.06% |
$24.4M - $44.1M
|
89.2K
$1.16M
|